Phase 2 NSCLC, Stage I Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
NSCLC, Stage I
Greg Durm, MD244 enrolled13 locationsNCT04317534
Recruiting
Phase 2
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
NSCLCNSCLC Stage IINSCLC, Stage I
Memorial Sloan Kettering Cancer Center25 enrolled7 locationsNCT07323732
Recruiting
Phase 2
Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC
NSCLC Stage IINSCLC, Stage IIIANSCLC Stage IIIB
University Hospital Heidelberg20 enrolled1 locationNCT04865250
Recruiting
Phase 2
Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients
NSCLC Stage IINSCLC, Stage IIIANSCLC, Stage I
University Hospital, Essen90 enrolled4 locationsNCT04205552
Recruiting
Phase 2
Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)
NSCLC, Stage I
Tianjin Medical University Cancer Institute and Hospital65 enrolled1 locationNCT05686434